Developments with Ketamine Psychotherapy Are Driving A Medical Revolution For Treating Mental Health Issues

Palm Beach, FL –October 28, 2021 – FinancialNewsMedia.com News Commentary  – Psychedelic drugs such as psilocybin, LSD and MDMA have tremendous medical and commercial future potential… and for ketamine, the “future” is now. Drug developers and clinic specialists offer numerous ketamine-related commercial opportunities. Psychedelic stock investors are used to regularly reading about “the renaissance in […]

MINDCURE Signs LOI with Awakn Life Sciences to Distribute Ketamine Protocol for Alcohol Use Disorder into Clinics Across United States and Canada through iSTRYM, MINDCURE’s Digital Therapeutics Platform

Vancouver, BC – October 28, 2021 – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) (“MINDCURE” or the “Company”), a leader in advanced proprietary technology and research for psychedelics, is pleased to announce the signing of a non-binding letter of intent (“LOI”) with Awakn Life Sciences (NEO: AWKN)(OTCQB: AWKNF) (“Awakn”), a biotechnology company […]